Healthcare Equipment and Supplies
Company Overview of ConvaTec Healthcare B S.a.r.l.
ConvaTec Healthcare B S.a.r.l. develops, manufactures, and markets medical technologies worldwide. It offers ostomy care products, including one- and two-piece ostomy systems, as well as accessories, such as pastes, powders, strips, seals, adhesive removers, and a special line of clothing; and wound dressings, including antimicrobial and foam dressings, and skin care products. The company also provides continence and critical care products comprising systems for managing acute fecal incontinence, monitoring urine production output, and monitoring intra-abdominal pressure; and disposable medical devices for use in high-volume procedures in urology, intensive care, operating rooms, and other h...
7 A Rue Robert Stumper
Founded in 2008
Key Executives for ConvaTec Healthcare B S.a.r.l.
Chief Executive Officer and Director
Senior Vice President of Operations
Chief Executive Officer of 180 Medical
Compensation as of Fiscal Year 2014.
ConvaTec Healthcare B S.a.r.l. Key Developments
ConvaTec Said To Mull Sale and IPO
Jul 1 14
ConvaTec Healthcare B S.a.r.l. has been approached by investment bankers and potential buyers to discuss a sale that could value the company at $8 billion to $9 billion, people familiar with the matter said. Avista Capital Partners and Nordic Capital won’t start a formal sale-process until later this year at the earliest, and are also considering an initial public offering for ConvaTec, the people said, asking not to be identified discussing private information. While ConvaTec is willing to wait until next year to sell or start a stock offering, the two owners have made it clear to advisers that they would sell at the right price sooner, one of the people said. One potential buyer is 3M Company (NYSE:MMM), one of the people said, though 3M is probably too large a buyer to use ConvaTec to change its tax domicile.
ConvaTec Healthcare B S.a.r.l. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012
Nov 29 12
ConvaTec Healthcare B S.a.r.l. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2012. For the quarter, the company reported net sales of $406.3 million compared to $411.3 million a year ago. Operating income was $63.1 million compared to $72.9 million a year ago. Loss before income taxes was $40.3 million compared to $26.1 million a year ago. Net loss was $50.6 million compared to $27.9 million a year ago. EBITDA was $108.2 million compared to $118.3 million a year ago. Adjusted EBITDA was $139.8 million compared to $126.3 million a year ago.
For the nine months, the company reported net sales of $1,181.1 million compared to $1,160.2 million a year ago. Operating income was $160.2 million compared to $145.8 million a year ago. Loss before income taxes was $166.6 million compared to $242 million a year ago. Net loss was $176.4 million compared to $228.7 million a year ago. EBITDA was $293.1 million compared to $281.2 million a year ago. Adjusted EBITDA was $340.5 million compared to $311 million a year ago. The $11.4 million increase in operating cash flow was driven by increased cash generated from operations, offset by changes in working capital. Additions to property, plant and equipment and capitalized software were $30.5 million compared to $20.7 million a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|